Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Management
Scientific Advisory Board
Corporate Governance
Our Science
Lead Drug Development
Cholesterol-Lowering Program
Brain Injury Program
Technical Glossary
Drug Development Pathway
Investors
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
Financial Reports
Investor Welcome
ASX Announcements
Brain Injury Program
Cholesterol-Lowering Program
Corporate Announcements
Investor Presentations
Financial Reports
Share Price Information
Key Dates
Investors Glossary
Financial Reports
Annual Reports
Analyst Reports
Annual General Meeting
Past Shareholder Meetings
Financial Reports
Filter by Year:
2023
2022
2021
2020
13-Oct-2020
Appendix 4C - September 2020 Quarterly Report
31-Aug-2020
FY 2020 Appendix 4E Preliminary Financial Report
22-Jul-2020
Appendix 4C - June 2020 Quarterly Report
22-Jul-2020
Appendix 4C - June 2020 Quarterly Report
14-Apr-2020
Appendix 4C - March 2020 Quarterly Report
25-Feb-2020
Appendix 4D and Half Yearly Accounts
1
